Mitochondria Specific Antioxidants and their Derivatives in the Context of the Drug Development for Neurodegeneration and Cancer

Gjumrakch Aliev^1,2*, Hector H Palacios³, Pablo Cacabelos⁴ and Ramon Cacabelos⁴

¹"GALLY" International Biomedical Research Consulting LLC, San Antonio, TX 78229, USA, E-mail: aliev03@gmail.com

²Department of Health Science and Healthcare Administration, University of Atlanta, Atlanta, GA 30360, USA, E-mail: aliev03@gmail.com

³Experimental Gerontology Section, Translational Gerontology Branch, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA, E-mail: aliev03@gmail.com

⁴EuroEspes Biomedical Research Center, Institute for CNS Disorders and Genomic Medicine & Camilo José Cela University, 15165 Bergondo, La Coruña, Spain, E-mail: aliev03@gmail.com

^*Corresponding Author: Dr. Gjumrakch Aliev, "GALLY" International Biomedical Research Consulting LLC, 7733 Louis Pasteur Drive, #328. San Antonio, TX, 78229, USA Email: